Global Oncolytic Virus Market Research Report 2019

Table of Contents

Executive Summary

1 Oncolytic Virus Market Overview

• 1.1 Product Overview and Scope of Oncolytic Virus
• 1.2 Oncolytic Virus Segment by Type
  • 1.2.1 Global Oncolytic Virus Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 HSV-based Oncolytic Viruses
  • 1.2.3 Adenoviruses-based Oncolytic Viruses
  • 1.2.4 Vaccinia Virus-based Oncolytic Viruses
  • 1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
  • 1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
• 1.3 Oncolytic Virus Segment by Application
  • 1.3.1 Oncolytic Virus Consumption Comparison by Application (2014-2025)
  • 1.3.2 Pharmaceutical
  • 1.3.3 Health Care
  • 1.3.4 Commerical
• 1.3 Global Oncolytic Virus Market by Region
  • 1.3.1 Global Oncolytic Virus Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Oncolytic Virus Market Size
  • 1.4.1 Global Oncolytic Virus Revenue (2014-2025)
  • 1.4.2 Global Oncolytic Virus Production (2014-2025)

2 Global Oncolytic Virus Market Competition by Manufacturers

• 2.1 Global Oncolytic Virus Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Oncolytic Virus Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Oncolytic Virus Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Oncolytic Virus Production Sites, Area Served, Product Types
• 2.5 Oncolytic Virus Market Competitive Situation and Trends
  • 2.5.1 Oncolytic Virus Market Concentration Rate
  • 2.5.2 Oncolytic Virus Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Oncolytic Virus Production Market Share by Regions

• 3.1 Global Oncolytic Virus Production Market Share by Regions
• 3.2 Global Oncolytic Virus Revenue Market Share by Regions (2014-2019)
• 3.3 Global Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Oncolytic Virus Production
  • 3.4.1 North America Oncolytic Virus Production Growth Rate (2014-2019)
  • 3.4.2 North America Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Oncolytic Virus Production
  • 3.5.1 Europe Oncolytic Virus Production Growth Rate (2014-2019)
  • 3.5.2 Europe Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Oncolytic Virus Production (2014-2019)
  • 3.6.1 China Oncolytic Virus Production Growth Rate (2014-2019)
  • 3.6.2 China Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Oncolytic Virus Production (2014-2019)
  • 3.7.1 Japan Oncolytic Virus Production Growth Rate (2014-2019)
  • 3.7.2 Japan Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Oncolytic Virus Consumption by Regions

• 4.1 Global Oncolytic Virus Consumption by Regions
• 4.2 North America Oncolytic Virus Consumption (2014-2019)
• 4.3 Europe Oncolytic Virus Consumption (2014-2019)
• 4.4 China Oncolytic Virus Consumption (2014-2019)
• 4.5 Japan Oncolytic Virus Consumption (2014-2019)

5 Global Oncolytic Virus Production, Revenue, Price Trend by Type

• 5.1 Global Oncolytic Virus Production Market Share by Type (2014-2019)
• 5.2 Global Oncolytic Virus Revenue Market Share by Type (2014-2019)
• 5.3 Global Oncolytic Virus Price by Type (2014-2019)
• 5.4 Global Oncolytic Virus Production Growth by Type (2014-2019)

6 Global Oncolytic Virus Market Analysis by Applications

• 6.1 Global Oncolytic Virus Consumption Market Share by Application (2014-2019)
• 6.2 Global Oncolytic Virus Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Oncolytic Virus Business

• 7.1 Merck
  • 7.1.1 Merck Oncolytic Virus Production Sites and Area Served
  • 7.1.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.1.3 Merck Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Otsuka Pharmaceutical Co
  • 7.2.1 Otsuka Pharmaceutical Co Oncolytic Virus Production Sites and Area Served
  • 7.2.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Pfizer
  • 7.3.1 Pfizer Oncolytic Virus Production Sites and Area Served
  • 7.3.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.3.3 Pfizer Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Roche
  • 7.4.1 Roche Oncolytic Virus Production Sites and Area Served
  • 7.4.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.4.3 Roche Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Cold Genesys
  • 7.5.1 Cold Genesys Oncolytic Virus Production Sites and Area Served
  • 7.5.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.5.3 Cold Genesys Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Genelux
  • 7.6.1 Genelux Oncolytic Virus Production Sites and Area Served
  • 7.6.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.6.3 Genelux Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Latima
  • 7.7.1 Latima Oncolytic Virus Production Sites and Area Served
  • 7.7.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.7.3 Latima Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Neotropix
  • 7.8.1 Neotropix Oncolytic Virus Production Sites and Area Served
  • 7.8.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.8.3 Neotropix Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Shanghai Sunway Biotech
  • 7.9.1 Shanghai Sunway Biotech Oncolytic Virus Production Sites and Area Served
  • 7.9.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.9.3 Shanghai Sunway Biotech Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 SillaJen
  • 7.10.1 SillaJen Oncolytic Virus Production Sites and Area Served
  • 7.10.2 Oncolytic Virus Product Introduction, Application and Specification
  • 7.10.3 SillaJen Oncolytic Virus Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Takara Bio
• 7.12 Theravir

8 Oncolytic Virus Manufacturing Cost Analysis

• 8.1 Oncolytic Virus Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Oncolytic Virus
• 8.4 Oncolytic Virus Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Oncolytic Virus Distributors List
• 9.3 Oncolytic Virus Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Oncolytic Virus Market Forecast

• 11.1 Global Oncolytic Virus Production, Revenue Forecast
  • 11.1.1 Global Oncolytic Virus Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Oncolytic Virus Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Oncolytic Virus Price and Trend Forecast (2019-2025)
• 11.2 Global Oncolytic Virus Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Oncolytic Virus Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Oncolytic Virus Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Oncolytic Virus Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Oncolytic Virus Production, Revenue Forecast (2019-2025)
• 11.3 Global Oncolytic Virus Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Oncolytic Virus Consumption Forecast (2019-2025)
  • 11.3.2 Europe Oncolytic Virus Consumption Forecast (2019-2025)
  • 11.3.3 China Oncolytic Virus Consumption Forecast (2019-2025)
  • 11.3.4 Japan Oncolytic Virus Consumption Forecast (2019-2025)
• 11.4 Global Oncolytic Virus Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Oncolytic Virus Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List